miR-200bc/429 cluster alleviates inflammation in IgA nephropathy by targeting TWEAK/Fn14

Int Immunopharmacol. 2017 Nov:52:150-155. doi: 10.1016/j.intimp.2017.09.002. Epub 2017 Oct 12.

Abstract

Immunoglobulin A nephropathy (IgAN) is one of the most common glomerular diseases worldwide. Various studies have identified a host of microRNAs (miRNAs) abnormally expressed in IgAN and might affect the pathogenesis and progression of IgAN. However, miR-200bc/429 cluster in the pathopoiesis of IgAN remains poorly understood. For this study, we found that miR-200bc/429 cluster is downregulated in IgAN tissues and IgAN podocytes and HK2 cells compared with their matched controls respectively. In addition, overexpression of miR-200bc/429 cluster in IgAN podocytes and HK2 cells could attenuate the release of inflammatory cytokines MCP-1, IL-6 and RANTES. Moreover, the 3' untranslated region (UTR) of TNF-like weak inducer of apoptosis (TWEAK) was identified to be a direct target of miR-200bc/429 cluster. Furthermore, our results showed that miR-200bc/429 cluster can inhibit TWEAK mediated NF-κB pathway activation in IgAN. Overall, our findings revealed that miR-200bc/429 cluster alleviates inflammation in IgAN through TWEAK/Fn14 system and might serve as a biomarker as well as a promising therapeutic target for IgAN.

Keywords: IgA nephropathy; Inflammatory response; NF-κB; TWEAK; miR-200bc/429 cluster.

MeSH terms

  • Aminosalicylic Acids / pharmacology
  • Animals
  • Apoptosis
  • Benzenesulfonates / pharmacology
  • Butadienes / pharmacology
  • Cell Line
  • Cytokine TWEAK / genetics*
  • Cytokine TWEAK / metabolism
  • Glomerulonephritis, IGA / genetics
  • Glomerulonephritis, IGA / immunology*
  • Glycation End Products, Advanced / metabolism
  • Inflammation / genetics
  • Inflammation / immunology*
  • Interleukin-6 / metabolism
  • MAP Kinase Signaling System
  • Mice
  • MicroRNAs / genetics*
  • Nitriles / pharmacology
  • Osteocytes / immunology*
  • STAT3 Transcription Factor / metabolism
  • Vascular Endothelial Growth Factor A / metabolism
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Aminosalicylic Acids
  • Benzenesulfonates
  • Butadienes
  • Cytokine TWEAK
  • Glycation End Products, Advanced
  • Interleukin-6
  • MIRN200 microRNA, human
  • MicroRNAs
  • NSC 74859
  • Nitriles
  • STAT3 Transcription Factor
  • Stat3 protein, mouse
  • TNFSF12 protein, human
  • U 0126
  • Vascular Endothelial Growth Factor A
  • p38 Mitogen-Activated Protein Kinases